Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children

Mahamadou S. Sissoko, Abdoulaye Dabo, Hamidou Traoré et al. · 2009

Read Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children by Mahamadou S. Sissoko, Abdoulaye Dabo, Hamidou Traoré et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006732.txt.

Description

Mahamadou S. Sissoko and colleagues tested a malaria drug combination against a parasitic worm disease in PLOS ONE in 2009. The disease is schistosomiasis caused by Schistosoma haematobium. It infects the urinary tract of many children in Africa. The standard treatment is praziquantel. The test drug paired artesunate with sulfamethoxypyrazine and pyrimethamine, at malaria doses.

School-aged children with the infection received one treatment or the other. The team then compared how well each cleared the parasite. A malaria drug that also cures schistosomiasis would be valuable where both diseases overlap. Mass treatment campaigns could then tackle two diseases together. The trial gives direct evidence on whether that shortcut works.

Catalog record

CREATORMahamadou S. Sissoko, Abdoulaye Dabo, Hamidou Traoré et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006732

Browse the full library · About the Tower of Babel